BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  First Patient Dosed in Phase II STARBURST Study of TLX250-CDx Exploring Indication Expansion

  Telix Pharmaceuticals Limited announces that the first patient has been dosed in a Phase II study of the Company’s carbonic anhydrase- -targeting PET/CT[1] imaging agent TLX250-CDx, exploring this potential target across a broad range of cancer indications.

  June 18, 2023

   · 

  6 min read
• Biotech Bay

  Vaxxas Opens World-Class Manufacturing Facility To Produce Proprietary Needle-Free Vaccine Patch For Late-Stage Clinical Trials and First Commercial Products

  Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform technology, announced the opening of its first, state-of-the-art manufacturing facility in Brisbane, Queensland.

  June 18, 2023

   · 

  8 min read